Xavier Doumen
Global Guide 2024
Band 6 : Corporate/M&A: High-end Capability
Band 6
Chambers Review
Global
Xavier Doumen draws upon his experience to advise clients on important cross-border mandates, notably acquisitions, divestments and corporate restructurings. He regularly serves clients from the manufacturing and energy fields.
Strengths
Provided by Chambers
"Xavier Doumen is a very good lawyer to have on a transaction. He will make the transaction progress and get your points across the table very clearly and convincingly."
"Xavier Doumen is highly dedicated and reliable, with a very good vision of the overall transaction. He leads the teams across jurisdictions to deliver complex deals and find solutions."
"I would say that Xavier Doumen is very committed, responsive and pragmatic with his advice."
"Xavier Doumen is a very good lawyer to have on a transaction. He will make the transaction progress and get your points across the table very clearly and convincingly."
"Xavier Doumen is highly dedicated and reliable, with a very good vision of the overall transaction. He leads the teams across jurisdictions to deliver complex deals and find solutions."
"I would say that Xavier Doumen is very committed, responsive and pragmatic with his advice."
Articles, highlights and press releases
1 item provided by Hogan Lovells (Paris) LLP
Hogan Lovells advises Shire in ex-U.S. closing of its US$2.4bn business sale to Servier S.A.S.
Hogan Lovells represented global biotechnology company Shire plc. in the ex-U.S. closing of the sale of its oncology business to Servier S.A.S., an independent international pharmaceutical company, for US$2.4 billion in cash.
Hogan Lovells advises Shire in ex-U.S. closing of its US$2.4bn business sale to Servier S.A.S.
Hogan Lovells represented global biotechnology company Shire plc. in the ex-U.S. closing of the sale of its oncology business to Servier S.A.S., an independent international pharmaceutical company, for US$2.4 billion in cash.
